Immediate Impact
1 from Science/Nature 74 standout
Citing Papers
Renal cell carcinoma
2024 Standout
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
2022 Standout
Works of I Tabah being referenced
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.
1997
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| I Tabah | 372 | 18 | 21 | 409 | 148 | 10 | 506 | |
| Ana Ayala | 266 | 13 | 23 | 373 | 190 | 16 | 462 | |
| G Stein | 293 | 13 | 11 | 412 | 198 | 8 | 509 | |
| Ling Chen | 322 | 20 | 48 | 397 | 208 | 16 | 538 | |
| L North | 283 | 49 | 31 | 370 | 142 | 15 | 466 | |
| Ulrich von Gruenhagen | 262 | 3 | 26 | 413 | 285 | 11 | 450 | |
| Deborah Turner | 295 | 34 | 35 | 442 | 161 | 13 | 537 | |
| M.H. Bennett | 178 | 103 | 14 | 357 | 52 | 13 | 435 | |
| Baha Alkuzweny | 253 | 5 | 24 | 363 | 178 | 7 | 450 | |
| K. Adams | 256 | 25 | 56 | 323 | 133 | 8 | 512 | |
| Greg Dueck | 332 | 3 | 54 | 458 | 219 | 13 | 550 |
All Works
Loading papers...